PATENT CLAIM ANALYSIS

Application Number: 15922815
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["536", "111000"]

Abstract:
The present application provides a pharmaceutical composition for use in inhibiting recurrence, aggravation or metastasis of liver cancer, in which the pharmaceutical composition comprises at least one compound having a structure of formula (I) and a pharmaceutically acceptable vehicle.

Claim (Index 11):
A method for inhibiting recurrence, aggravation and/or metastasis of liver cancer, comprising administering to a patient in need thereof the pharmaceutical composition of  claim 1 .

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.18919
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14901297', '15614412', '15651060', '15179153', '15613711']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6084840929994438
- 35 USC 102 Novelty (BERT): 0.4859112530912359
- Combined Prediction Score: 0.596226809008623
- Mean Citation Score: 197.529832
- Max Citation Score: 203.69781
- Similarity Product: 140.14888172563255

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test